Should Third-World countries pay the tab for new drug development?

• 1 March 1999
• journal article
• Published by Wolters Kluwer Health in Academic Medicine
• Vol. 74  (3) , 203
• https://doi.org/10.1097/00001888-199903000-00001

Abstract

Keywords

• *CHEMISTRY
• PHARMACEUTICAL (ECONOMICS)
• COST CONTROL (TRENDS)
• *DEVELOPING COUNTRIES
• *DRUG COSTS (TRENDS)
• *DRUG INDUSTRY (ECONOMICS)
• HUMAN
• INTERNATIONAL COOPERATION
• PATENTS